MedPath

Stiftung Swiss Tumor Institute

🇨🇭Switzerland
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

ePRO for the Timely Detection of Side Effects in Cancer Patients Undergoing CAR T Immunotherapy

Recruiting
Conditions
CAR T-Cell Therapy
Patient Reported Outcome Measures
First Posted Date
2022-05-02
Last Posted Date
2024-04-19
Lead Sponsor
Stiftung Swiss Tumor Institute
Target Recruit Count
11
Registration Number
NCT05354973
Locations
🇨🇭

Klinik für Hämatologie und Onkologie, Zürich, Switzerland

The Possible Influence of Different Follow-up Modalities on Overall Survival in Ovarian Cancer

Terminated
Conditions
Patient Reported Outcome Measures
Ovarian Neoplasms
First Posted Date
2022-04-28
Last Posted Date
2024-04-22
Lead Sponsor
Stiftung Swiss Tumor Institute
Target Recruit Count
7
Registration Number
NCT05352217
Locations
🇨🇭

Spital Limmattal Frauenklinik, Schlieren, Zürich, Switzerland

🇨🇭

Gynäkologische Onkologie Spital Zollikerberg, Zollikerberg, Zürich, Switzerland

🇨🇭

Praxis für Gynäkologie und Geburtshilfe, Zürich, Switzerland

and more 1 locations

News

No news found
© Copyright 2025. All Rights Reserved by MedPath